| Clinical data | |
|---|---|
| Drug class | DopamineD1 receptoragonist;Stimulant |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C19H20BrNO2 |
| Molar mass | 374.278 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
6-Br-APB is asynthetic andselectivedopamineD1 receptoragonist andstimulant-likedrug of the3-benzazepine family.[1] It is acyclized phenethylamine andmodifiedderivative of themonoamine neurotransmitterdopamine.[2] The (R)-enantiomer is apotent dopamine D1 receptorfull agonist, while the (S) enantiomer retains selectivity but is a weakpartial agonist of the receptor.[3] (R)-6-Br-APB and similar dopamine D1 receptor-selective full agonists likeSKF-81,297 andSKF-82,958 produce characteristicanorectic effects,stereotyped behaviour, andself-administration in animals, with a similar but not identical profile to that of dopaminergic stimulants such asamphetamine.[4][5][6]
Thisdrug article relating to thenervous system is astub. You can help Wikipedia byadding missing information. |